Skip to main content
GANX logo

GANX · Gain Therapeutics, Inc. · Short Interest

Track GANX — free
$1.66 +0.05 (+2.79%) At close · Oct 9
Market Cap
$71.58M
Shares
43.64M
Volume · Oct 9 328.7K Avg daily vol (3M) 495.89K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

GANX Latest Reported Short Interest

FINRA reported 3,056,188 GANX shares sold short as of the September 30, 2026 settlement date, an increase of 169,037 shares. Days to cover was 5.93 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

GANX Short Interest Forecast

Equibles' model estimates 3,171,279 shares sold short for the October 15, 2026 settlement, +3.8% versus the latest reported position, with a likely range of 2,833,152 to 3,588,718 shares. This model prediction uses FINRA data through October 9, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 9 High confidence 68% chance it rises
3,171,279 +3.8% vs reported
Likely range 2,833,152 to 3,588,718 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
63/100
Short interest 7.0% of shares — P80 Days to cover 5.9 — P77 Price vs VWAP -11.1% — P32 Short-volume trend -0.9% — P48 Short interest change +5.9% — P65 Worst FTD 0.01% of shares — P54

Positioning score 63.3 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-10 01:06 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 3,056,188 2,887,151 +169,037 5.93
2026-09-15 2,887,151 2,795,819 +91,332 8.88
2026-08-31 2,795,819 2,952,391 -156,572 7.65
2026-08-14 2,952,391 3,213,359 -260,968 4.89
2026-07-31 3,213,359 3,588,085 -374,726 6.65
2026-07-15 3,588,085 3,608,175 -20,090 4.05
2026-06-30 3,608,175 3,869,330 -261,155 1.81
2026-06-15 3,869,330 3,198,541 +670,789 6.06
2026-05-29 3,198,541 3,160,772 +37,769 3.86
2026-05-15 3,160,772 3,442,408 -281,636 7.22
2026-04-30 3,442,408 3,331,182 +111,226 6.33
2026-04-15 3,331,182 3,282,560 +48,622 5.79
2026-03-31 3,282,560 2,873,797 +408,763 4.03
2026-03-13 2,873,797 2,883,705 -9,908 3.59
2026-02-27 2,883,705 3,039,619 -155,914 4.08
2026-02-13 3,039,619 2,976,352 +63,267 5.92
2026-01-30 2,976,352 2,482,134 +494,218 3.74
2026-01-15 2,482,134 2,666,410 -184,276 1.83
2025-12-31 2,666,410 2,073,310 +593,100 1.00
2025-12-15 2,073,310 1,260,732 +812,578 1.50
2025-11-28 1,260,732 1,781,339 -520,607 1.28
2025-11-14 1,781,339 910,705 +870,634 1.16
2025-10-31 910,705 1,270,541 -359,836 1.37
2025-10-15 1,270,541 422,327 +848,214 1.13

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 1819411 CUSIP 36269B105 13F (30d) 2 filings 2 filers Visit website Investor relations